Clinical Psychology Review
September 9, 2015
Sarah Reeve, Bryony Sheaves, Daniel Freeman
Background: Sleep dysfunction is extremely common in patients with schizophrenia. Recent research indicates that sleep dysfunction may contribute to psychotic experiences such as delusions and hallucinations. Objectives: The review aims to evaluate the evidence for a relationship between sleep dysfunction and individual psychotic experiences, make links between the theoretical understanding of...
Canadian Medical Association Journal
September 8, 2015
Kenneth W. Tupper, Evan Wood, Richard Yensen et al.
189 citations
In clinical research settings around the world, renewed investigations are taking place on the use of psychedelic substances for treating illnesses such as addiction, depression, anxiety and posttraumatic stress disorder (PTSD). Since the termination of a period of research from the 1950s to the
Health technology assessment
September 2015
Willem Kuyken, Rachel Hayes, Barbara Barrett et al.
Individuals with a history of recurrent depression have a high risk of repeated depressive relapse/recurrence. Maintenance antidepressant medication (m-ADM) for at least 2 years is the current recommended treatment, but many individuals are interested in alternatives to m-ADM. Mindfulness-based cognitive therapy (MBCT) has been shown to reduce the risk of relapse/recurrence compared with usual...
Emergency Medicine News
September 1, 2015
Leon Gussow
Figure: Phenethylamine, top left; 2C-I, top right; and 25I-NBOMe, below.FigureAt least 19 young people died between March 2012 and November 2013 from the so-called N-BOMB drugs, synthetic hallucinogens that can be deadlier than LSD, according to the U.S. Drug Enforcement Administration. Chemist Alexander Shulgin developed a series of hallucinogenic 2C drugs in the early 1970s by adding...
Translational Psychiatry
September 1, 2015
Chun Yang, Yukihiko Shirayama, J-C Zhang et al.
600 citations
Although the efficacy of racemate ketamine, a rapid onset and sustained antidepressant, for patients with treatment-resistant depression was a serendipitous finding, clinical use of ketamine is limited, due to psychotomimetic side effects and abuse liability. Behavioral and side-effect evaluation tests were applied to compare the two stereoisomers of ketamine. To elucidate their potential...
Routledge eBooks
August 27, 2015
Sheldon Z. Kramer
1 citation
This chapter establishes Kabbalistic concepts and methods and demonstrates how these teachings are used to heal psychological discord and spiritual deprivation. The mystical dimension can be integrated into everyday life when one follows an inner and outer discipline reflecting these teachings. The chapter explains combining mindfulness-based cognitive therapy which helps to decrease anxiety...
International Journal of Yoga
August 26, 2015
Manish J Parswani, Mahendra P. Sharma, S S Iyengar
Background: Psychological risk factors such as anxiety and depression have been associated with coronary heart disease (CHD). Stress can have an impact on the risk factors for the disease, such as high blood pressure (BP), physical inactivity and being overweight. Aims: Examine the effect of the Mindfulness-Based Stress Reduction (MBSR) program on symptoms of anxiety and depression, perceived...
International Journal of Yoga
August 26, 2015
Thaiyar M Srinivasan
Byline: T. Srinivasan Instability in body-mind gives rise to self-discovery and an altered state of consciousness. This is the experience of most people. Especially, when the instability portends facing bodily death, one's inner search is intense, and one may go through depression, despair and denial. In such extreme cases, a model for the human existence is important. It has been said that...
August 25, 2015
Phuong-Tu Prowse, T. Nagel, G. Meadows
Mindfulness Based Cognitive Therapy (MBCT) continues to gain evidential support as an intervention to impact on relapse and recurrence of depression. Researchers and MBCT Clinicians seek higher levels of treatment fidelity to maximise positive outcomes, through the use of treatment manuals, assessment scales and other supporting tools. Semi-structured group interviews with MBCT trained...
Trials
August 25, 2015
Mariyana Schoultz, Iain Atherton, Angus Watson
Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition with a relapsing disease course. Managing the relapsing nature of the disease causes daily stress for IBD patients; thus, IBD patients report higher rates of depression and anxiety than the general population. Mindfulness-based Cognitive Therapy (MBCT) is an evidence-based psychological program designed to help manage...